Fertility Market in the US 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Regulatory scenario in the US

PART 06: Market landscape

• Market overview
• Five forces analysis

PART 07: Infertility: An overview

• Etiology
• Etiology: Female infertility
• Signs and symptoms
• Tests and diagnosis
• Treatment

PART 08: Stages of fertility treatment

PART 09: Cost analysis of ART

• Direct cost
• Indirect cost

PART 10: Market segmentation by type

• Infertility drugs
• Fertility drugs market in US
• ART
• ART market in US

PART 11: Market drivers

• Emergence of ART and acceptance of same-sex marriage
• Increasing success rate of infertility treatment
• Increase in infertility complications

PART 12: Impact of drivers

PART 13: Market challenges

• High cost of fertility treatment
• Complications of fertility services
• Limited reimbursement
• Minimal regulations

PART 14: Impact of drivers and challenges

PART 15: Market trends

• Increase in M&A
• Rise in R&D
• Establishment of new fertility clinics

PART 16: Vendor landscape

• Competitive scenario
• Key news
• Mergers and acquisitions
• Licensing and collaborations
• Market share analysis
• Other prominent vendors

PART 17: Appendix

• List of abbreviations

PART 18: Explore Technavio